Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Ferring collaborates on novel IBD drug development

Project in partnership with Paris-based Institut Pasteur

- PMLiVE

Survey reveals problems with lung cancer mutation testing

A quarter of patients surveyed not receiving EGFR testing prior to treatment

- PMLiVE

Merck files Keytruda for lung cancer

Filed to the FDA as a treatment option for NSCLC patients

Harnessing the power of genetics

In oncology, and other therapy areas, personalised medicines offer new hope against chronic illnesses

Big Data – the next big thing

The ‘Internet of Things’ age is truly upon us

- PMLiVE

Mission Critical

When it’s lonely at the top, leaders can seek a critical friend

Don’t use the ‘SM’ words!

'Social media' should be avoided - unless you want seasoned industry types to start heading for the hills

- PMLiVE

Rise of generics will curb France’s pharma growth

Generics are set to take a serious bite out of the market as a cash-strapped government pushes for cost controls

- PMLiVE

AZ and Takeda drugs should carry heart failure warning

FDA panel claim diabetes drugs Onglyza and Nesina need label updates

- PMLiVE

Quality in Care Hepatitis C programme open for entry

PMGroup's QiC programme aims to recognise best practice in care for hepatitis C in the UK

- PMLiVE

BMS gives Erbitux rights to Lilly in the US

Firm wants to focus on its burgeoning PD-1 cancer range

- PMLiVE

First generic version of Teva’s Copaxone cleared by FDA

Will be marketed as Glatopa by Momenta and Novartis’ Sandoz subsidiary

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links